Enlitic (ASX:ENL) Valuation Rank

View and export this data going back to 2023. Start your Free Trial

What is Enlitic Valuation Rank?

The Valuation Rank measures the current valuation of a business relative to other companies in the same industry and its own historical valuation. The companies are split in equal numbers and then ranked from 1 to 10, with 10 as the most undervalued and 1 as the most overvalued.

Three factors:
- Absolute valuation (medpsvalue) relative to current stock price, rank among all companies
- Historical valuation over the past 10 years. Rank pe, ps, pocf, ev2ebit over their own historical values
- Industry relative valuation
Companies without enough data is not ranked
Companies with negative earnings are ranked lower

These three factors are used to calculate the value score for every eligible company, with values from 1 to 10. The final ranked companies are split in equal numbers and ranked from 1 to 10, with 10 as the most undervalued, and 1 as the most overvalued. The numbers of companies in each rank are the same.

Enlitic Valuation Rank Related Terms

Thank you for viewing the detailed overview of Enlitic's Valuation Rank provided by GuruFocus.com. Please click on the following links to see related term pages.

Enlitic (ASX:ENL) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Enlitic Inc (ASX:ENL) » Definitions » Valuation Rank

Comparable Companies

Traded in Other Exchanges

N/A

Address

3420 East Harmony Road, Suite 125, Fort Collins, CO, USA, 80528

Website

https://www.enlitic.com

Enlitic Inc is focused on artificial intelligence that enables effective administration, processing, and sharing of medical imaging data throughout the healthcare enterprise. It is also focused on developing tools that solve longstanding challenges in radiology rather than developing point solutions that exacerbate the issues radiology faces. Enlitic provides a solid plan that addresses data inconsistencies and risk associated with moving studies containing PHI and is focused on using AI for the medical imaging layer of a real-world evidence (RWE), providing healthcare organizations with a stepwise approach to operationalizing their AI.